Tell me the stage of carcinoma

Reading File
Reading File
Reading File
Reading File
Reading File
Running Command

python3 -c " import pdfplumber, os files = { 'GGN': '/home/daytona/workspac…

I now have all the data needed. Here is the complete staging analysis:

Carcinoma Staging - Mrs. Prem Narula (82F, Right Breast)

Data Extracted from the Three Reports

ReportKey Findings
Biopsy (7 Jul 2026)Invasive Ductal Carcinoma, Grade 2; ER+ (Allred 8/8), PR+ (Allred 7/8), HER2- (IHC 1+); Ki-67 15-18%; No lymphovascular invasion
Mammography (4 Jul 2026)Right breast retroareolar irregular spiculated mass ~3 x 2 cm (BIRADS 5); right axillary tail mass 12 x 12 mm (BIRADS 4); skin thickening and retraction
PET/CT (13 Jul 2026)Primary lesion 2.0 x 1.8 x 2.4 cm (SUVmax 9.2), skin involvement/NAC involvement; FDG-avid right axillary stations I and III nodes (largest 1.1 x 0.9 cm, SUVmax 5.0); No distant metastases

TNM Staging (AJCC 8th Edition)

ParameterValueRationale
TT2Tumor ~2-3 cm; skin retraction and NAC involvement present but tumor does not directly invade chest wall or cause ulceration/edema qualifying for T4
NN1FDG-avid ipsilateral axillary lymph nodes at levels I and III - metastatic (clinically node-positive, cN1)
MM0No distant metastatic disease on PET/CT whole body scan

Overall Clinical Stage: Stage IIB (cT2 N1 M0)

If the axillary nodes are pathologically confirmed at surgery, this could upgrade to Stage IIIA (pT2 pN2) if 4 or more nodes are involved, but based on imaging currently it appears to be 1-3 nodes - most consistent with Stage IIB.

Molecular Subtype

MarkerResult
ERPositive (>95%, Allred 8/8)
PRPositive (85-90%, Allred 7/8)
HER2Negative (IHC 1+)
Ki-6715-18% (intermediate)
SubtypeLuminal B (HR+/HER2-)
Ki-67 of 15-18% sits at the border of Luminal A vs Luminal B. Many guidelines (St. Gallen) use a cut-off of 20%; however, given Grade 2 histology and the intermediate Ki-67, this is best classified as Luminal B-like.

Summary

Mrs. Prem Narula has Stage IIB (cT2 N1 M0) Invasive Ductal Carcinoma of the right breast, Grade 2, Luminal B (HR+/HER2-) subtype.
  • Primary tumor: ~2-3 cm, retroareolar, with skin/NAC involvement
  • Regional nodes: Right axillary levels I & III involved (metastatic)
  • Distant disease: None detected
  • Favorable receptor profile (strongly ER/PR positive, HER2 negative) - suitable for endocrine therapy as a key component of systemic treatment
This is a shared conversation. Sign in to Orris to start your own chat.